Notice of Closed Meeting, 23359 [2020-08808]
Download as PDF
<![CDATA[
23359
Federal Register / Vol. 85, No. 81 / Monday, April 27, 2020 / Notices
department of the four hospital sites
with febrile illness, and will be
interviewed to gather information on
symptoms, possible exposures, and
medical history, in addition to having
diagnostic samples collected to test for
leptospirosis plus or minus melioidosis
(depending on presenting symptoms).
reservoirs related to human
leptospirosis illness in Puerto Rico.
The estimated annualized burden
hours requested are 1,675. There is no
cost to respondents other than their
time.
Participants will then also be
interviewed approximately two weeks
after enrollment to determine illness
progression and outcome. Patients
testing positive for leptospirosis, if
willing, may have animals sampled
from their home or work environments,
if present, to help determine the animal
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Patient
Patient
Patient
Patient
Patient
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
...............................................
...............................................
...............................................
...............................................
...............................................
PIFA (screening) ..............................
PIFA (full form: Sections 1–4, 11) ...
Consent Form ..................................
PIFF ..................................................
Animal Household Survey ................
7,000
3,000
3,000
1,000
250
1
1
1
1
1
5/60
10/60
6/60
10/60
30/60
583
500
300
167
125
Total ...........................................
...........................................................
........................
........................
........................
1,675
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–08794 Filed 4–24–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
lotter on DSKBCFDHB2PROD with NOTICES
Number of
respondents
Form name
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)–
CE15–002: The CDC National Centers of
Excellence in Youth Violence
Prevention: Building the Evidence for
Community- and Policy-Level
Prevention.
VerDate Sep<11>2014
17:32 Apr 24, 2020
Jkt 250001
Date: June 17, 2020.
Time: 8:30 a.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Mikel Walters, Ph.D., Scientific Review
Official, NCIPC, CDC, 4770 Buford
Highway NE, Mailstop F–63, Atlanta,
Georgia 30341, Telephone (404)639–
0913, MWalters@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–08808 Filed 4–24–20; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Change in Reporting
Requirements for The Federal
Cigarette Labeling and Advertising Act
(FCLAA) and Comprehensive
Smokeless Tobacco Health Education
Act (CSTHEA)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces that
it is extending the March 31, 2020
deadline for submissions required under
the Federal Cigarette Labeling and
Advertising Act (FCLAA) and the
Comprehensive Smokeless Tobacco
Health Education Act (CSTHEA) for
cigarette and smokeless tobacco
products, respectively. CDC also
announces that it is extending the
deadline for ingredient reports for new
products that are due at the time of first
importation. Previous notices
announced that ingredient reports are
due annually on March 31, and/or upon
initial importation of cigarettes and/or
smokeless tobacco products. Due to the
current public health response to
COVID–19, CDC is not able to accept
any ingredient submissions and will not
be issuing Certificates of Compliance at
this time. CDC is communicating this
information to state government entities
and will re-evaluate this approach as
necessary.
SUMMARY:
E:\FR\FM\27APN1.SGM
27APN1
]]>Agencies
[Federal Register Volume 85, Number 81 (Monday, April 27, 2020)]
[Notices]
[Page 23359]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08808]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)-CE15-002: The CDC National Centers
of Excellence in Youth Violence Prevention: Building the Evidence for
Community- and Policy-Level Prevention.
Date: June 17, 2020.
Time: 8:30 a.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Mikel Walters, Ph.D., Scientific
Review Official, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F-63,
Atlanta, Georgia 30341, Telephone (404)639-0913, [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-08808 Filed 4-24-20; 8:45 am]
BILLING CODE 4163-18-P
